S J S Enterprises Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/rkj9c9bva20fy1w1l1mz3fk2.pdf

Key Takeaways


Automotive Outperformance


Export Markets: Near-Term Pain, Long-Term Conviction

Thapar: "These are near-term challenges that we see. The long-term outlook for exports remains extremely bullish for the simple reason that the market size, as I said, is very large. And we are also on the enlisted panel as a global strategic supplier to these customers."

Margins: Expansion with Headroom

Thapar: "I'm happy to deliver more than I promised. So that is what our DNA is. So on a steady-state basis, that's what my guidance remains unchanged. So I'm still at 25% to 27%. I know we've done 27.7%. I'd be happier if I do 30% on a consolidated basis."

Futuristic Products: The Next Growth Cycle

Thapar: "So we are very, very excited about this technology. We are thankful to our customers that are working closely with us. And going forward, this could be a complete game changer as to what are the SJS portfolio of products to the customers."

Exotech: Capacity-Stretched but Growing

Thapar: "It is, to be honest, it is touch and go. So that plant was not built for such robust growth. So 50% we grew last year. This year, I'll grow 25% and the outlook for the year after that again is 25%. So it will take some doing. But then we are sweating the asset for all its worth to try and achieve the target."

Inorganic Strategy: Opportunistic and Accretive


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthAround 25% Y-o-YFY23
PAT growthClose to 30% Y-o-Y and moving beyondFY23 and coming years
Consolidated EBITDA margin25%-27% steady-stateOngoing
Export recoveryPossible recovery toward end of Q3 or early Q4, conditional on market settlingEnd-Q3 / early Q4 FY23
Export share of salesReach 25% of overall salesThree-year goal (by ~FY25)
Exotech growth25% Y-o-YFY23 and FY24
Exotech new plantOn streamQ3/Q4 FY24
Exotech steady-state margin~15% ballparkSteady-state
Standalone capacityDouble FY22 revenues on current capacity; additional 60,000-70,000 sq ft ready5-6 months for new space
Cover glass / optical plastics capexCapex plans to be built once volume visibility firms upComing quarter or so for visibility
Medium-term guidance (FY23-FY25)MaintainedFY23 to FY25

Key Metrics

MetricQ2 FY23
Consolidated revenue₹116.94 cr, +17.3% YoY
Sequential revenue growth+13.3% QoQ
EBITDA₹33.38 cr, +24.5% YoY
EBITDA margin28.0%, +134 bps YoY and +161 bps QoQ
PAT₹19.95 cr, +30.7% YoY
PAT margin17.1%, +175 bps YoY and +135 bps QoQ
H1 FY23 revenue growth+26.5% YoY
H1 FY23 PAT growth+46% YoY to ₹36.16 cr
FY23 revenue growth guidance~25% YoY, maintained
FY23 PAT growth guidanceclose to 30% YoY
Consolidated EBITDA margin guidance25% to 27%, maintained; H1 averaged 27.7%
Automotive segment growth (2W+PV)+30.3% YoY, vs industry production growth of +12.1%
Two-wheeler sales growth+31.3% YoY, vs industry volume growth of +7.7%
Passenger vehicle sales growth+28.9% YoY, vs industry volume growth of +38.1%
Domestic sales growth+22.9% YoY and +12.5% QoQ
Export revenue growth (excl. Europe & North America)+5.7% YoY
Cash and cash equivalents~₹129.51 cr as on 30 Sep 2022; net debt-free
H1 FY23 free cash flow₹32.26 cr added; FCF to EBITDA at 52.7%
ROCE34.8% as on 30 Sep 2022
ROE16.7% as on 30 Sep 2022
Standalone Bangalore plant capacity utilization~60%; can double FY22 revenues with current capacity
Exotech steady-state margin guidance15% ballpark; Q2 benefited from softer raw material prices
Exotech growth trajectory+50% in FY22, guided +25% in FY23, outlook +25% for FY24
New Exotech plant timelineExpected towards end of FY24 (Q3 or Q4); 12–18 months to commission
FY23 capex plan~₹55–60 cr total (~₹15 cr regular + ~₹40 cr chrome-plating expansion); ~₹50 cr in H2
New-age products share of sales (FY22)16%; could reach 30–40% in coming years
EV manufacturers supplied12 leading EV OEMs in India
Quality awards won in Q28 awards